Reported 226,819 shares, up 114,583 (102.1%) from the prior quarter.
Reported value 160.7%; share count 102.1% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-03-31 | 3460000 |
| 2022-06-30 | 5540000 |
| 2022-09-30 | 7686000 |
| 2022-12-31 | 6855576 |
| 2023-03-31 | 4890704 |
| 2023-06-30 | 4025226 |
| 2023-09-30 | 2976070 |
| 2023-12-31 | 4916261 |
| 2024-03-31 | 5585033 |
| 2024-06-30 | 5226448 |
| 2024-09-30 | 6082811 |
| 2024-12-31 | 4996638 |
| 2025-03-31 | 4029080 |
| 2025-06-30 | 3122015 |
| 2025-09-30 | 3466798 |
| 2025-12-31 | 3963849 |
| 2026-03-31 | 3535434 |
| 2026-06-30 | 9215656 |
| 2026-09-30 | 9005851 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 221,819 | -5,000 (-2.2%) | 1.92% | $9,005,851 | 2026-11-16 | |
| Q2 2026 | Added | 226,819 | +114,583 (102.1%) | 1.76% | $9,215,656 | 2026-08-14 | |
| Q1 2026 | Reduced | 112,236 | -47,500 (-29.7%) | 0.8% | $3,535,434 | 2026-05-15 | |
| Q4 2025 | Reduced | 159,736 | -54,000 (-25.3%) | 0.92% | $3,963,849 | 2026-02-17 | |
| Q3 2025 | Reduced | 213,736 | -24,404 (-10.2%) | 0.86% | $3,466,798 | 2025-11-14 | |
| Q2 2025 | Added | 238,140 | +55,000 (30.0%) | 0.86% | $3,122,015 | 2025-08-14 | |
| Q1 2025 | Reduced | 183,140 | -4,000 (-2.1%) | 1.14% | $4,029,080 | 2025-05-15 | |
| Q4 2024 | Reduced | 187,140 | -40,766 (-17.9%) | 1.27% | $4,996,638 | 2025-02-14 | |
| Q3 2024 | Reduced | 227,906 | -62,291 (-21.5%) | 1.44% | $6,082,811 | 2024-11-14 | |
| Q2 2024 | Reduced | 290,197 | -16,000 (-5.2%) | 1.25% | $5,226,448 | 2024-08-14 | |
| Q1 2024 | Reduced | 306,197 | -143,187 (-31.9%) | 1.27% | $5,585,033 | 2024-05-15 | |
| Q4 2023 | Reduced | 449,384 | -70,000 (-13.5%) | 1.18% | $4,916,261 | 2024-02-14 | |
| Q3 2023 | Unchanged | 519,384 | 0 (0.0%) | 0.93% | $2,976,070 | 2023-11-14 | |
| Q2 2023 | Reduced | 519,384 | -213,855 (-29.2%) | 1.1% | $4,025,226 | 2023-08-14 | |
| Q1 2023 | Reduced | 733,239 | -33,604 (-4.4%) | 1.47% | $4,890,704 | 2023-05-15 | |
| Q4 2022 | Reduced | 766,843 | -14,269 (-1.8%) | 1.93% | $6,855,576 | 2023-02-14 | |
| Q3 2022 | Added | 781,112 | +85,153 (12.2%) | 2.07% | $7,686,000 | 2022-11-14 | |
| Q2 2022 | Added | 695,959 | +339,209 (95.1%) | 1.51% | $5,540,000 | 2022-08-15 | |
| Q1 2022 | New | 356,750 | +356,750 (0.0%) | 0.9% | $3,460,000 | 2022-05-16 |
Who else reported the position
254 managers reported EDGEWISE THERAPEUTICS INC for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Unchanged | 15,518,492 | 0 | 11.75% | $630,516,330 | 22 qtrs |
| Paradigm Biocapital Advisors LP | Added | 10,215,455 | +2,850,417 | 7.77% | $415,053,937 | 10 qtrs |
| RA CAPITAL MANAGEMENT L P | Reduced | 8,392,730 | -2,035,707 | 2.96% | $340,996,620 | 10 qtrs |
| BlackRock Inc | Added | 6,606,336 | +133,345 | < 0.01% | $268,415,431 | 8 qtrs |
| Jupiter Topco LLC | New | 6,075,331 | +6,075,331 | 0.1% | $246,945,299 | 1 qtr |
| FMR LLC | Added | 5,489,135 | +4,472,083 | < 0.01% | $223,023,556 | 22 qtrs |
| Novo Holdings A S | Unchanged | 5,350,000 | 0 | 12.62% | $217,370,500 | 22 qtrs |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Added | 4,728,623 | +250,681 | 1.11% | $192,123,952 | 11 qtrs |
| PERCEPTIVE ADVISORS LLC | Reduced | 4,373,974 | -50,000 | 2.67% | $177,714,564 | 11 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 3,860,670 | +72,509 | < 0.01% | $156,859,022 | 2 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 14, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 226,819
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.